News | October 06, 2014

ProNova and medPhoton to Offer Next Generation Beam Delivery, Advanced Imaging for Proton Therapy

ProNova medPhoton Next Generation Beam Delivery Advanced Imaging Proton Therapy

October 6, 2014 — ProNova Solutions and medPhoton announced that they have agreed to form an exclusive partnership that will merge leading edge pencil beam IMPT and innovative integrated imaging into a unique next generation offering for the proton therapy market.

ProNova will integrate the medPhoton ImagingRing system into the SC360 proton therapy solution. The resulting system will include Fast Scanning IMPT technology with integrated 3-D imaging. This unique solution merges leading edge pencil beam delivery, innovative dual-energy 3-D imaging capability and precision positioning to aid physicians and therapists in minimizing collateral damage to healthy tissue and maximizing dose to the tumor. The ProNova compact superconducting gantry design allows for 360 degrees of patient treatment angle and improved workflow, resulting in faster treatment times and higher productivity.

medPhoton´s newly developed ImagingRing system is a slim, couch based, in-room CBCT device, capable of large field of view, low dose, single source dual energy 3-D volumetric and 2-D planar image acquisitions. It supports smooth workflows and highest precision in inter- and intrafractional image guided radiotherapy.

“medPhoton is glad that our hard research and development work over the last years will now have a real impact on the field. After having installed our first unit at the carbon beam facility MedAustron, we will now integrate our slim imaging ring system with ProNova’s cutting edgesmall footprint proton therapy equipment. In combination of both systems, precise beam adaptation and tracking of moving targets will be possible in the near future. A series of joint installations, research and clinical has been ordered,” says Heinz Deutschmann, chief executive officer and founder of medPhoton.

“ProNova is proud to partner with an innovative company like medPhoton,” said Joe Matteo, division president of ProNova Solutions, R&D and manufacturing. “Together we feel that this unique solution will enable clinicians to develop advanced proton therapy protocols for Adaptive Therapy.”

For more information: www.medphoton.at, pronovasolutions.com

Related Content

RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic radiotherapy system...
Overlay Init